Polygiene AB (POLYG) AI Stock Analysis

0 Followers

Polygiene AB

(Nasdaq OMX AB:POLYG)

Select Model

Rating:44Neutral

Price Target:SEK 2.50▼(-3.85% Downside)

Action:reiterated

Date:10/28/26

The score is held down primarily by weakened financial performance (TTM losses and negative free cash flow) and a bearish technical setup (below major moving averages with negative MACD). A strong, low-leverage balance sheet provides stability, but valuation is difficult to justify with a negative P/E and no dividend support in the provided data.

Positive Factors

Low LeverageA near-zero debt burden gives Polygiene financial flexibility and reduces refinancing exposure as it manages an uneven earnings profile. Stable equity relative to assets also provides resilience, allowing the company to pursue operations without the same balance-sheet pressure as a highly leveraged competitor.

Negative Factors

Revenue and Profitability DeclineFalling revenue combined with renewed operating and net losses signals weakened demand conversion and insufficient cost absorption. Unless growth returns, the lower sales base can limit reinvestment, reduce operating leverage, and make the company’s improved gross margin less meaningful to sustainable earnings.

Polygiene AB (POLYG) vs. iShares MSCI Sweden ETF (EWD)

Market Cap: SEK 96.07M
Dividend Yield: ―
Average Volume (3M): 52.87K
Price to Earnings (P/E): -21.8
Beta (1Y): 0.25
Revenue Growth: -18.26%
EPS Growth: 35.77%
Country: Sweden
Employees: 34
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals - Specialty

Polygiene AB Business Overview & Revenue Model

Company Description

Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equi...

Polygiene AB Financial Statement Overview

Summary

Overall fundamentals are pressured: the income statement shows deteriorating profitability with TTM revenue down (-7.3%) and negative EBIT/net income, while cash flow is a major weakness with negative TTM operating cash flow and free cash flow. Offsetting this, the balance sheet is a clear strength with very low leverage and stable equity, reducing solvency risk but not fixing near-term earnings/cash burn.

Income Statement

41Neutral

Balance Sheet

82Very Positive

Cash Flow

33Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	127.52M	146.65M	156.95M	113.54M	173.56M	181.61M
Gross Profit	48.04M	48.32M	103.78M	77.16M	114.57M	115.24M
EBITDA	-1.35M	5.96M	18.80M	-304.02M	20.34M	43.99M
Net Income	-4.29M	-5.58M	16.83M	-321.95M	8.36M	32.83M
Balance Sheet
Total Assets	307.06M	304.74M	350.84M	313.78M	621.90M	550.69M
Cash, Cash Equivalents and Short-Term Investments	34.20M	38.78M	68.59M	44.15M	48.06M	52.40M
Total Debt	2.02M	4.57M	2.63M	3.89M	1.64M	2.40M
Total Liabilities	19.91M	28.56M	31.23M	22.53M	29.34M	31.54M
Stockholders Equity	287.15M	276.17M	319.61M	291.25M	592.56M	519.15M
Cash Flow
Free Cash Flow	-5.62M	-11.04M	22.75M	-4.27M	-50.64M	34.15M
Operating Cash Flow	-4.13M	-9.79M	24.34M	3.79M	-1.54M	37.60M
Investing Cash Flow	-2.19M	-4.07M	-1.59M	-9.42M	-52.11M	-407.47M
Financing Cash Flow	-5.83M	-9.67M	-1.38M	1.95M	47.50M	416.27M

Polygiene AB Technical Analysis

Technical Analysis SentimentNegative

Last Price2.60

Price Trends

50DMA3.36Negative

100DMA4.07Negative

200DMA5.42Negative

Market Momentum

MACD-0.28Positive

RSI41.50Neutral

STOCH57.34Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Negative. The current price of 2.60 is below the 20-day moving average (MA) of 2.91, below the 50-day MA of 3.36, and below the 200-day MA of 5.42, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 41.50 is Neutral, neither overbought nor oversold. The STOCH value of 57.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

SE:POLYG against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:PCAT	69Neutral	SEK 20.62M	4.53	―	―	-17.14%	88.76%
SE:HPOL.B	68Neutral	SEK 32.81B	17.89	12.33%	4.47%	-0.82%	-7.46%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SE:SCA.A	60Neutral	SEK 87.16B	40.16	2.14%	2.46%	-3.07%	-38.98%
SE:POLYG	44Neutral	SEK 96.07M	-21.79	-1.52%	―	-18.26%	35.77%
SE:NEXAM	41Neutral	SEK 254.18M	-12.25	-9.37%	―	-4.57%	-15.20%
SE:ORGC	31Underperform	SEK 89.59M	-1.41	-176.65%	―	-21.95%	-28.77%

* Basic Materials Sector Average

Performance Comparison

SE:POLYG and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SE:POLYG	Polygiene AB	2.60	-6.46	-71.30%
SE:HPOL.B	Hexpol AB	93.95	14.78	18.67%
SE:NEXAM	Nexam Chemical Holding AB	2.50	-0.67	-21.14%
SE:SCA.A	Svenska Cellulosa Aktiebolaget Class A	122.00	-0.15	-0.12%
SE:ORGC	OrganoClick AB	0.43	-1.26	-74.72%
SE:PCAT	Photocat A/S	3.42	-0.38	-10.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026

Polygiene AB AI Stock Analysis